Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-16

FDA Approved: DIFLUPREDNATE OPHTHALMIC EMULSION — Original Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

The FDA approved Dr. Reddy's Difluprednate Ophthalmic Emulsion (0.05%) as an original application, providing a generic option for treating ocular inflammation a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Difluprednate ophthalmic emulsion (difluprednate)

Snippet

ORIG AP for DIFLUPREDNATE OPHTHALMIC EMULSION (DIFLUPREDNATE OPHTHALMIC)